First Time Loading...
C

China Isotope & Radiation Corp
HKEX:1763

Watchlist Manager
China Isotope & Radiation Corp
HKEX:1763
Watchlist
Price: 9.25 HKD -1.6% Market Closed
Updated: Apr 20, 2024

Operating Margin
China Isotope & Radiation Corp

14.2%
Current
14%
Average
4.4%
Industry
Positive for the last year
14.2%
Positive average
14%
Better than average
Better than industry value

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.2%
=
Operating Profit
941.7m
/
Revenue
6.6B

Operating Margin Across Competitors

Operating Margin Comparison
China Isotope & Radiation Corp Competitors

Country Company Market Cap Operating
Margin
CN
China Isotope & Radiation Corp
HKEX:1763
3B HKD
14%
JP
Hoya Corp
TSE:7741
6.1T JPY
28%
CH
Alcon AG
SIX:ALC
35.8B CHF
12%
DK
Coloplast A/S
CSE:COLO B
203.7B DKK
28%
US
Align Technology Inc
NASDAQ:ALGN
22.4B USD
17%
US
Cooper Companies Inc
NYSE:COO
18B USD
15%
KR
HLB Inc
KOSDAQ:028300
13T KRW
-291%
UK
ConvaTec Group PLC
LSE:CTEC
5.8B GBP
116%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
50.8B CNY
45%
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
6.3B USD
7%
CH
Ypsomed Holding AG
SIX:YPSN
5.2B CHF
16%
C
China Isotope & Radiation Corp
HKEX:1763
Country CN
Market Cap 3B HKD
Operating Margin
14%
Hoya Corp
TSE:7741
Country JP
Market Cap 6.1T JPY
Operating Margin
28%
Alcon AG
SIX:ALC
Country CH
Market Cap 35.8B CHF
Operating Margin
12%
Coloplast A/S
CSE:COLO B
Country DK
Market Cap 203.7B DKK
Operating Margin
28%
Align Technology Inc
NASDAQ:ALGN
Country US
Market Cap 22.4B USD
Operating Margin
17%
Cooper Companies Inc
NYSE:COO
Country US
Market Cap 18B USD
Operating Margin
15%
H
HLB Inc
KOSDAQ:028300
Country KR
Market Cap 13T KRW
Operating Margin
-291%
ConvaTec Group PLC
LSE:CTEC
Country UK
Market Cap 5.8B GBP
Operating Margin
116%
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Country CN
Market Cap 50.8B CNY
Operating Margin
45%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Country US
Market Cap 6.3B USD
Operating Margin
7%
Ypsomed Holding AG
SIX:YPSN
Country CH
Market Cap 5.2B CHF
Operating Margin
16%

Profitability Report

View the profitability report to see the full profitability analysis for China Isotope & Radiation Corp.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.2%
=
Operating Profit
941.7m
/
Revenue
6.6B
What is the Operating Margin of China Isotope & Radiation Corp?

Based on China Isotope & Radiation Corp's most recent financial statements, the company has Operating Margin of 14.2%.

ALPHA SPREAD
Join more than 129,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.